PATENT CLAIM ANALYSIS

Application Number: 16431270
Application Type: Utility
Filing Date: 2019-06
Publication Date: 2019-10
Patent Classification: ["424", "134100"]

Abstract:
Compositions comprising synthetic membrane-receiver complexes, methods of generating synthetic membrane-receiver complexes, and methods of treating or preventing diseases, disorders or conditions therewith.

Claim (Index 13):
The enucleated erythroid cell of  claim 1 , which is a human cell.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 100.0
- Lexical Diversity: 1.44444
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16409576', '15783921', '15925212', '16195811', '15824877']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8233041317237101
- 35 USC 102 Novelty (BERT): 0.6334566498458494
- Combined Prediction Score: 0.804319383535924
- Mean Citation Score: 605.9000679999998
- Max Citation Score: 611.0706
- Similarity Product: 549.2780512323618

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test